Patent · US Expired

Method of treating prostatic adenocarcinoma

US5637310A · kind A · utility

17Cited by
9References
2Claims
0Family size

Assignee

Inventor

Key dates

Filing dateMay 30, 1995
Grant dateJun 10, 1997
Priority date
Expiry dateMay 30, 2015

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/568
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Invented is a Method of Treating Prostatic Adenocarcinoma by employing asteroid 5-.alpha.-reductase inhibiting compound or a combination of steroid 5-.alpha.-reductase inhibiting compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.